These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6331618)

  • 1. In vivo proteins of defective interfering particles of poliovirus.
    Tershak DR
    Can J Microbiol; 1984 Apr; 30(4):461-9. PubMed ID: 6331618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of poliovirus-specific polypeptide aggregates.
    Korant BD
    J Virol; 1973 Sep; 12(3):556-63. PubMed ID: 4355854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain.
    Kajigaya S; Arakawa H; Kuge S; Koi T; Imura N; Nomoto A
    Virology; 1985 Apr; 142(2):307-16. PubMed ID: 2997988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidine-resistant defective interfering particles of poliovirus.
    Tershak DR
    J Virol; 1982 Feb; 41(2):615-25. PubMed ID: 6281472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins.
    Anderson-Sillman K; Bartal S; Tershak DR
    J Virol; 1984 Jun; 50(3):922-8. PubMed ID: 6328023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents.
    Wetz K; Habermehl KO
    J Gen Virol; 1979 Aug; 44(2):525-34. PubMed ID: 230294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus.
    Kew OM; Pallansch MA; Omilianowski DR; Rueckert RR
    J Virol; 1980 Jan; 33(1):256-63. PubMed ID: 6245231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particles RNAs, and fingerprint of the poliovirus type 3 genome.
    Lee YF; Kitamura N; Nomoto A; Wimmer E
    J Gen Virol; 1979 Aug; 44(2):311-22. PubMed ID: 230285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsid protein precursor is one of two initiated products of translation of poliovirus RNA in vitro.
    Humphries S; Knauert F; Ehrenfeld E
    J Virol; 1979 May; 30(2):481-8. PubMed ID: 224212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDS-acrylamide gel electrophoresis and its application to the proteins of poliovirus- and adenovirus-infected human cells.
    Maizel JV; Summers DF; Scharff MD
    J Cell Physiol; 1970 Dec; 76(3):273-87. PubMed ID: 4322980
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Electrophoretic resolution of poliovirus capsid polypeptides in the presence of a pH gradient.
    Vrijsen R; Boeyé A
    Arch Int Physiol Biochim; 1976 Feb; 84(1):205-6. PubMed ID: 60968
    [No Abstract]   [Full Text] [Related]  

  • 15. Ebola virus: identification of virion structural proteins.
    Kiley MP; Regnery RL; Johnson KM
    J Gen Virol; 1980 Aug; 49(2):333-41. PubMed ID: 7441205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of subviral particles and assembly activity in HeLa cells infected with defective-interfering (DI) particles of poliovirus.
    Phillips BA; Lundquist RE; Maizel JV
    Virology; 1980 Jan; 100(1):116-24. PubMed ID: 6243195
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypeptide composition of urea- and heat-resistant mutants of poliovirus types 1 and 2.
    Fennell R; Phillips BA
    J Virol; 1974 Oct; 14(4):821-33. PubMed ID: 4371460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state infection by echovirus 6 associated with nonlytic viral RNA and an unprocessed capsid polypeptide.
    Righthand VF; Blackburn RV
    J Virol; 1989 Dec; 63(12):5268-75. PubMed ID: 2585604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free synthesis and processing of the proteins of poliovirus.
    Shih DS; Shih CT; Kew O; Pallansch M; Rueckert R; Kaesberg P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5807-11. PubMed ID: 215997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and structural relatedness among non-capsid and capsid polypeptides of polioviruses belonging to different serotypes.
    Romanova LI; Tolskaya EA; Agol VI
    J Gen Virol; 1981 Feb; 52(Pt 2):279-89. PubMed ID: 6169783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.